logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Junping Zhao

This inventor holds 7 USPTO granted patents and 3 EPO patents. Top assignees: Novartis Ag, Arrowhead Pharmaceuticals, Inc.. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junping Zhao. Retrieved from https://idiyas.com/inventor/junping-zhao-m5f2gapp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.4

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Waltham, MA (US) (2016 - 2020)
  • Cambridge, MA (US) (2016 - 2020)
  • Arlington, MA (US) (2019 - 2021)

Company Filing History:

goldMedal5 out of 3,977 
 
Novartis Ag
 patents
silverMedal2 out of 102 
 
Arrowhead Pharmaceuticals, Inc.
 patents

Years Active: 2016-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 11066667 - Organic compositions to treat APOC3-related diseases (2021-07-20),
2. 10792361 - Lipids and lipid compositions for the delivery of active agents (2020-10-06),
3. 10729775 - Lipids and lipid compositions for the delivery of active agents (2020-08-04),
4. 10240153 - Organic compositions to treat APOC3-related diseases (2019-03-26),
5. 10124065 - Lipids and lipid compositions for the delivery of active agents (2018-11-13),
6. 9504747 - Lipids and lipid compositions for the delivery of active agents (2016-11-29),
7. 9301923 - Lipids, lipid compositions, and methods of using them (2016-04-05),

Title: Junping Zhao: Innovator in Biomedicine

Introduction

Junping Zhao is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biomedicine. With a total of 7 patents, he has focused on developing innovative solutions for various health-related issues.

Latest Patents

Zhao's latest patents include groundbreaking work on organic compositions to treat APOC3-related diseases. This patent addresses conditions such as hypertriglyceridemia, abnormal lipid metabolism, and cardiovascular diseases by utilizing RNAi agents targeting APOC3. Another notable patent involves lipids and lipid compositions designed for the effective delivery of active agents to cells and tissues, showcasing his commitment to advancing therapeutic methods.

Career Highlights

Throughout his career, Junping Zhao has worked with leading companies in the pharmaceutical industry, including Novartis AG and Arrowhead Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in medical treatments.

Collaborations

Zhao has collaborated with notable professionals in his field, including Jeremy Lee Baryza and Keith Bowman. These partnerships have further enhanced his research and development efforts.

Conclusion

Junping Zhao's innovative work in biomedicine continues to impact the treatment of various diseases. His patents reflect a dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…